Arkolith/Insider Trading/ARQT/Form 4

Leonard Keith R

DirectorArcutis Biotherapeutics, Inc. (ARQT) · full profile →Form 4 · filed Mar 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$997K
Net Open-Market Flow
-$997K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)39K$25.39$997K22K
Mar 2, 2026Option exercise(M)12K$7.51$92K61K
Mar 2, 2026Option exercise(M)27K$8.63$233K49K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)12K—$00
Mar 2, 2026Option exercise(M)27K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-014642) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML